Drug - Stimulants
July 2016
Therapeutic Area - ADD/ADHD
Beginning July 5, 2016, stimulant medications will be limited to the maximum FDA approved daily dose.
Drug | Common brand names | Maximum daily dose |
Amphetamine extended-release |
Adzenys XR-ODT
|
18.8 mg/day (6-12 years); 12.5 mg (13 years and older)
20 mg/day |
Atomexetine | Strattera | 100 mg/day |
Dexmethylphenidate | Focalin and generics | 20 mg/day |
Dexmethylphenidate extended-release | Focalin XR and generics | 40 mg/day |
Dextroamphetamine | Dexedrine, ProCentra,and generics | 60 mg/day |
Lixdexamfetamine | Vyvanse | 70 mg/day |
Methylphenidate | Ritalin and generics | 60 mg/day |
Methylphenidate extended-release | Concerta and generics
Aptensio XR |
72 mg/day
60 mg/day |
Methylphenidate patches | Daytrana | 30 mg/day |
Methylphenidate solution, suspension | Quillivant XR | 60 mg/day |
Methylphenidate chewable tablets | Quillichew ER | 60 mg/day |
Mixed amphetamine salts | Adderall, Adderall XR*, generics | 60 mg/day |
MHCP Provider Call Center 651-431-2700 or 800-366-5411